bionaut logo.png
 

Founded by serial entrepreneurs (previously built and sold Primesense to Apple for ~$400M), Bionaut Labs is developing remotely controlled microbots that can actively move through various tissue types for precision delivery, diagnostics and micro-surgical procedures. The team has achieved breakthroughs on the design of the microbots allowing for speedy navigation and flexible payloads, as well as an efficient magnetic propulsion system that is order of magnitude weaker than an MRI. The initial target is to freely traverse the central nervous system and deliver existing therapeutics on command, in controlled doses and in specific locations for indications around pain management and spinal muscular atrophy.